We have studied ceBNIP3, the orthologue of BNIP3 in C. elegans. Sequence analysis reveals that the dierent domains of BNIP3 have been conserved throughout evolution. ceBNIP3 contains a C-terminal transmembrane (TM) domain, a conserved domain (CD) of 19 amino acids, a BCL-2 homology-3 (BH3)-like domain and a PEST sequence. ceBNIP3 is expressed primarily as a 25 kDa monomer and a 50 kDa homodimer. After transfection, ceBNIP3 protein is rapidly degraded through a ubiquitin-dependent pathway by the proteasome. Like BNIP3, the TM domain of ceBNIP3 mediates the localization of the protein to mitochondria and is also necessary for homodimerization and cell death in mammalian cells. Neither the putative BH3 domain nor conserved domain is necessary for killing. ceBNIP3 protein interacts with CED-9 and BCL-X L , but unlike other pro-apoptotic BCL-2 family members, the BH3-like domain does not participate in dimerization. The ceBNIP3 TM domain mediates interaction with both CED-9 and BCL-X L . ceBNIP3 interacts with CED-3 but co-expression of CED-3 and ceBNIP3 does not signi®cantly enhance induction of cell death in the presence or absence of CED-4. ceBNIP3 kills mammalian cells by a caspase-independent mechanism. In conclusion, we ®nd that although ceBNIP3 interacts with CED-9 and CED-3 it kills by a BH3-and caspaseindependent mechanism.
Introduction
Apoptosis or programmed cell death is an evolutionarily conserved process in multicellular organisms that plays an essential role in development and tissue homeostasis (Vaux and Korsmeyer, 1999) . Genetic analysis of programmed cell death in the nematode Caenorhabditis elegans has identi®ed several components of the apoptotic pathway . Mutations in ced-9, ced-3, ced-4 and egl-l aect the death of 131 somatic cells that occurs during normal development. Loss-of-function mutations of ced-3, ced-4 and egl-l result in the survival of the cells that would normally die, thereby involving these genes in the killing process (Ellis and Horvitz, 1986) . In contrast, the ced-9 gene protects cells that normally survive from undergoing apoptosis (Hengartner et al., 1992) . Mammalian homologs have been identi®ed for all three genes. Ced-3 encodes a protein similar to the cysteine proteases family called caspases (Alnemri et al., 1996) whereas ced-4 shares homology with Apaf-1 and CARD/Nod1 (Zou et al., 1997; Bertin et al., 1999; Inohara et al., 1999) . The mammalian counterpart of ced-9 is Bcl-2 and it has been shown that Bcl-2 can partially replace ced-9 in C. elegans (Vaux et al., 1992; Hengartner and Horvitz, 1994) . The genetic studies and physical interactions between these three genes have provided a model to explain the regulation of apoptosis in C. elegans. First, the genetic studies in the worm have demonstrated that ced-9 acts upstream of ced-4 and ced-3 (Hengartner et al., 1992) . Using the yeast two hybrid system, it has been shown that CED-9 interacts with CED-4 (Wu et al.; Spector et al., 1997) , which also binds the CED-3 protein (Chinnaiyan et al., 1997) and prevents the activation of CED-3 by CED-4 (Seshagiri and Miller, 1997) . Egl-1, which interacts with CED-9 through its BH3 domain, has been shown to induce apoptosis in C. elegans (Conradt and Horvitz, 1998) . The proposed model is that the interaction of Egl-1 with CED-9 releases CED-9 from the complex and consequently permits oligomerization of CED-4, thereby bringing together multiple CED-3 proteins (Yang et al., 1998) . Recently, both CED-9 and CED-4 proteins have been localized to the mitochondria in wild type embryos. After activation of Egl-1, CED-4 translocates to the nucleus and this event precedes any CED-3 processing .
BNIP3 (BCL-2 and Nineteen kDa interacting protein-3) and NIX (also called BNIP3a/BNIP3L/B5) form a unique subfamily of death inducing mitochondrial proteins (Chen et al., 1997 Yasuda et al., 1999; Matsushima et al., 1998; Ohi et al., 1999) . Both mammalian proteins have the same features: a Cterminal TM domain, a putative BH3 domain and a PEST sequence Yasuda et al., 1999) . When overexpressed, BNIP3 and NIX localize to the mitochondria and induce cell death. However, a TM deletion mutant of both proteins is expressed primarily in the cytosol and has no apoptotic activity . In vivo, BNIP3 and NIX are expressed as dimers and for BNIP3, the TM domain also mediates homodimerization Ray et al., 2000) . Both proteins are also rapidly degraded in vivo and the degradation is blocked by lactacystin treatment, a proteasome inhibitor . BNIP3 and NIX can overcome BCL-2 or BCL-X L suppression of apoptosis although a high level of BCL-X L expression will inhibit killing activity. BNIP3 co-immunoprecipitates with BCL-2 or BCL-X L and deletion mapping studies have identi®ed the NH-2 terminus or the TM domain as critical for the interaction and have excluded the BH3 domain (Ray et al., 2000) . In another study, using the yeast two hybrid system, the ability of BNIP3 without the BH3 domain to heterodimerize with BCL-X L is somewhat reduced (Yasuda et al., 1998a) . Deletion of the BH3 domain of BNIP3 has no eect on cell death (Ray et al., 2000) .
Overexpression of BNIP3 induces cell death as a consequence of early Dcm loss and ROS production which is blocked by cyclosporin A or bongkrekic acid, inhibitors PT pore opening . In contrast, BNIP3 overexpression does not induce cytochrome c release and the broad spectrum caspase inhibitor Ac-zVAD.fmk was ineective in blocking cell death, suggesting that BNIP3-mediated cell death is caspase-independent .
ceBNIP3, an orthologue of BNIP3 in C. elegans, shows 21% amino acid sequence identity with BNIP3 and shares similar structural features to mammalian BNIP3 (Yasuda et al., 1998b) . Overexpression of ceBNIP3 induces apoptosis in mammalian cells and ceBNIP3 interacts with CED-9 and CED-3 as a ternary complex (Yasuda et al., 1998b) . The interaction of CED-3 and ceBNIP3 increases the processing of CED-3 into an active form and consequently cell death leading the authors to propose that ceBNIP3 may function as a CED-4-like protein.
In this report, we have characterized the domains of ceBNIP3 that are required for cell death and interaction with CED-9. ceBNIP3 contains a TM domain, a conserved domain of 19 amino acids, a putative BH3 domain and a PEST sequence. After transient transfection, ceBNIP3 induces cell death and only the TM domain is critical for localization to the mitochondria and killing function. ceBNIP3 is also capable of homodimerization and heterodimerization with CED-9 and BCL-X L through its TM domain, and cell death is partially suppressed by BCL-X L . We ®nd that ceBNIP3 heterodimerizes with CED-3 but does not enhance CED-3 killing activity and induces cell death in a caspase-independent manner.
Results

Homology between ceBNIP3 and BNIP3
We searched the C. elegans database for homologous sequences using segments of the human BNIP3 amino acid sequence. Only one stretch of 19 amino acid residues within an open reading frame (ORF) of 210 amino acids was found at locus CEC14F5 on chromosome III of C. elegans (Accession number U29082) as reported by Yasuda et al., 1998b . Sequence analysis revealed two possible start codons 33 nucleotides apart containing an imperfect Kozak sequence. So in our studies, we used the ®rst ATG and obtained an ORF encoding a protein of 221 amino acids (Accession number AF133832) in contrast to the sequence reported by Yasuda et al., 1998b . Human BNIP3 and the potential ceBNIP3 showed 21% identity over their entire amino acid sequences. Further analysis of the BNIP3 subfamily sequences revealed that BNIP3, NIX and ceBNIP3 share several common structural features (Figure 1a ). The three proteins have a C-terminal a-helical hydrophobic TM domain. They each contain a putative BH3 domain with some key amino acids (Figure 1b) . The N-terminus of BNIP3, NIX and ceBNIP3 contain PEST sequences, which are found in proteins that are rapidly degraded in the proteasome. The three proteins also share a span of conserved amino acids, 17 of 19 for mouse mBNIP3 and 14 of 19 for mouse mNIX.
ceBNIP3 protein expression
We compared in vitro transcribed and translated products of ceBNIP3 and BNIP3 by Laemmli SDS ± PAGE (Figure 2a) . The predicted molecular weight of BNIP3 is approximately 21.5 kDa, however BNIP3 runs as a 60 kDa dimer and a 30 kDa monomer. ceBNIP3 has a predicted molecular weight of 24.8 kDa and on SDS ± PAGE runs as a major band of 27 kDa corresponding to the T7 tagged-monomer. A minor band running slightly faster is probably due to translation from the second initiation codon. Weak bands at approximately 50 kDa correspond to a putative ceBNIP3 dimer. Deletion of the TM domain results in a 25 kDa translated product with no dimeric form, suggesting that the homodimerization of ceB-NIP3 is probably mediated by the TM domain, similar to BNIP3 and NIX (Chen et al., 1997 Ray et al., 2000) . To con®rm this result, we used the yeast two hybrid assay to determine whether ceBNIP3 homodimerizes through the TM domain. Figure 2b shows that ceBNIP3 is able to interact with itself but not with the ceBNIP3DTM mutant, supporting the hypothesis that this region is critical for homodimerization.
Subcellular localization of ceBNIP3
The presence of a potential C-terminal TM domain in ceBNIP3 prompted us to examine the subcellular localization of ceBNIP3. BNIP3 and NIX are found to co-localize with mitochondrial matrix protein HSP60 (Chen et al., 1997 and deletion of the C-terminal results in diuse cytoplasmic staining (Chen et al., 1997 . MCF-7 cells were transiently transfected with N-terminal T7-tagged ceBNIP3. After 24 h, cells expressing ceBNIP3 showed a punctate pattern characteristic of intracellular membrane localization, possibly mitochondrial. By simultaneously staining with mouse monoclonal anti-T7 and rabbit anti-HSP60, and goat anti-mouse Cy3-conjugated secondary antibody and goat anti-rabbit FITC-conjugated secondary antibody, distribution of the proteins could be visualized by confocal¯uorescent microscopy. The ceBNIP3 and HSP60¯uorescence had a similar punctate pattern (Figure 3a,b) and overlays of the images illustrated extensive but not total overlap (not shown). In contrast, ceBNIP3DTM was diusely stained throughout the cell (Figure 3c,d) . These results suggest that ceBNIP3, like BNIP3 and NIX is localized to the mitochondria via the C-terminal TM domain.
Overexpression of ceBNIP3 in mammalian cells induces cell death
Since BNIP3 and NIX have been shown to induce apoptosis, we transiently transfected 293T or 10T1/2 cells with T7 epitope-tagged ceBNIP3. At the indicated times, cells were stained with mouse anti-T7 antibody to identify transfected cells and Hoechst dye to assess apoptosis by nuclear chromatin condensation. 293T cells became apoptotic at 12 h after ceBNIP3 transfection and reached a peak of 45% at 48 h, compared to 60% for human BNIP3 (Figure 4a ). After 36 h, 80% of the 10T1/2 cells expressing BNIP3 or ceBNIP3 were apoptotic ( Figure 4b ). These results con®rm that ceBNIP3 is able to induce apoptosis in mammalian cell lines nearly as eciently as BNIP3.
The same experiment was repeated using T7 epitopetagged ceBNIP3DTM. Previously, we had shown that BNIP3 or NIX without a TM domain was not targeted to the mitochondria and was unable to induce apoptosis, implying that mitochondrial localization was necessary (Chen et al., 1997 . Similarly, when 293T or 10T1/2 cells were transiently transfected with the T7 epitope-tagged ceBNIP3DTM, no cell death was evident after 48 h (Figure 4a ,b). ceBNIP3 has a putative BH3 domain (amino acids 124 ± 138) and a conserved domain (amino acids 132 ± 151). To examine the potential role of these domains in cell death, the deletion mutants T7-ceBNIP3DBH3 and T7-ceBNIP3DCD were transiently transfected into 293T or 10T1/2 cells. Figure 4a ,b shows that the deletion of either of these domains had no eect on the ability of the protein to induce cell death despite similar levels of protein expression to wild type ceBNIP3 ( Figure 6a ).
After transient co-transfection of the 293T cells with the full length or various deletion mutants of ceBNIP3 and the b-galactosidase reporter gene, cell death was measured by counting the blue rounded cells after staining. Only the deletion of the TM domain could abrogate cell death induced by ceBNIP3 (Figure 4c ). Cell death measured by the b-galactosidase assay is much more rapid with near maximum killing by 12 h, . At the indicated times, the cells were ®xed and stained with mouse monoclonal anti-T7 antibody using FITC. The frequency of apoptotic cells was quantitated by Hoechst dye staining. The curves represent the mean+s.e. of three independent experiments. (c) 293T were transiently co-transfected with the reporter plasmid pcDNA3-b-gal and either ceBNIP3, ceBNIP3DTM, ceBNIP3DCD, ceBNIP3DBH3 or BNIP3. At the indicated time, cells were ®xed, stained and evaluated for cell death. The data represent the mean+s.e. of three independent experiments while apoptosis as measured by chromatin condensation is absent at 12 h and peaks between 36 and 48 h (Figure 4c ).
BCL-X L suppression of ceBNIP3 apoptosis
It has been shown that BNIP3 and NIX-induced apoptosis are partially suppressed by BCL-2 and BCL-X L (Chen et al., 1997 . In this report, we used two 10T1/2 cell lines that express a high level and a moderate level of BCL-X L (Figure 5c ). After transient transfection, BCL-X L suppression in TX22 cell line, the moderate expressing line, partially suppresses ceBNIP3 and to about the same extent as BNIP3 (Figure 5a,b) . In the TX5 cell line, the high expressing line, BCL-X L almost completely suppresses both ceBNIP3 and BNIP3 (Figure 5a,b) .
Ac-zVAD.fmk cannot block ceBNIP3-induced cell death BNIP3-induced cell death is caspase-independent . The eect of the broad spectrum caspase inhibitor Ac-zVAD.fmk was examined after transient transfection of 293T cells with ceBNIP3 or BNIP3, using BID as a caspase-dependent pro-apoptotic positive control. Ac-zVAD.fmk (50 mM) did not prevent cell death induced by ceBNIP3 or BNIP3 (Figure 5d ). In contrast, BID-induced cell death was inhibited by over 50% (Figure 5d ). Another experiment using 100 mM Ac-zVAD.fmk yielded the same results (data not shown).
ceBNIP3 protein expression is regulated by the proteasome
The expression of ceBNIP3 in vivo following 293T cell transfection was measured by Western blotting of post nuclear lysates with anti-T7 antibody. ceBNIP3 reached peak expression between 12 and 24 h but was followed by progressive decrease over time ( Figure  6a ). The decrease was not correlated with increased apoptosis as ceBNIP3DTM was also degraded in a similar manner without cell death (Figure 6a) . Removal of the CD domain did not aect protein turn over (Figure 6a ). The expression of BNIP3 or NIX was similar, reaching a maximum by 24 h and then rapidly decreasing over time (Chen et al., 1997 .
ceBNIP3, BNIP3 and NIX contain PEST sequences that are found on proteins targeted to the proteasome. 293T cells were transiently transfected with T7-ceBNIP3 and treated with 5 mM lactacystin, an inhibitor of the threonine protease of the proteasome (Fenteany et al., 1995) . ceBNIP3 protein accumulated in the presence of lactacystin even after 48 h, whereas without treatment, most of the protein is degraded (Figure 6b ). To assess the role of ubiquitination in the degradation of ceBNIP3 through the proteasome, we used the TS20 cell line (Chowdary et al., 1994) which contains a temperature sensitive mutation in the E1 enzyme that is necessary for the ubiquitination of proteins targeted for degradation. At 348C, the E1 enzyme is active, but becomes inactive at 398C. TS20 and its parental cell line, H38 were transiently transfected with T7-ceBNIP3 and following 12 h post-transfection, the temperature was shifted to 398C. The cells were collected every 8 h and the lysates Western blotted for ceBNIP3 expression. As shown in Figure 7 , there was an accumulation of ceBNIP3 in TS20 cells at 398C compared to H38 or TS20 cells at 348C, suggesting that a ubiquitination step is necessary for the proteasome processing of ceBNIP3.
Heterodimerization of ceBNIP3 with BNIP3, CED-9 and BCL-X L The observation that BNIP3 physically interacts with adenovirus E1B 19K, a BCL-2 functional orthologue, as well as BCL-2 (Boyd et al., 1994; Ray et al., 2000) prompted us to examine the heterodimerization of ceBNIP3 with CED-9, BCL-X L and as well BNIP3. In the yeast two hybrid assay, ceBNIP3 interacts with CED-9, BCL-X L and BNIP3 (Figure 8a ). To determine whether ceBNIP3 bound to CED-9 in vivo, cotransfections were performed in 293T cells. We found that following immunoprecipitation (IP) of HA-CED-9, we detected T7-ceBNIP3 by Western blot as both a monomer and a dimer (Figure 8b) . Similarly, following IP of ceBNIP3, we detected CED-9 by Western blot (Figure 8b, bottom) . To determine the domain necessary for the ceBNIP3 binding, 293T cells were co-transfected with CED-9 and ceBNIP3 or mutants without BH3, TM or conserved domains. As shown in Figure 8b , CED-9 immunoprecipitated with ceB-NIP3DCD and ceBNIP3DBH3 as eciently as the full length ceBNIP3. However, CED-9 co-immunoprecipitation of ceBNIP3DTM or ceBNIP3DBH3TM was virtually undetectable (Figure 8b ) leaving only a faint band still seen after over exposure of the blot (not shown). The same pattern was obtained in reciprocal co-immunoprecipitation experiment of CED-9 with ceBNIP3 and the BH3, TM and CD mutants ( Figure  8b , bottom). As a control, 293T were co-transfected with T7-ceBNIP3 and FLAG-DR3 and after immunoprecipitation of ceBNIP3, no DR3 was detectable and vice versa (not shown). The co-immunoprecipitations of BCL-X L and ceBNIP3 deletion mutants showed exactly the same pattern as CED-9 co-immunoprecipitation (Figure 8c ). These results were con®rmed using yeast two hybrid system. No interactions were detected between ceBNIP3DTM and CED-9 or BCL-X L in contrast to ceBNIP3 (Table 1) .
Interaction of ceBNIP3 and CED-3
Yasuda et al., 1998b reported that ceBNIP3 interacts with CED-3 (Figure 9a ). To determine the region of interaction between ceBNIP3 and CED-3, 293T cells were co-transfected with CED-3 and ceBNIP3, ceB-NIP3DTM, ceBNIP3DCD, ceBNIP3DN1 (deletion of the ®rst 26 amino acids), ceBNIP3DN2 (deletion of the ®rst 54 amino acids). CED-3 immunoprecipitated with all ceBNIP3 deletion mutants, thus we were unable to de®ne any single domain or region that accounted for the interaction (Figure 9a) .
293T cells were then co-transfected with ceBNIP3, CED-3 and CED-4 alone, with combinations of ceBNIP3/CED3, CED3/CED-4, ceBNIP3/CED-3/ CED-4 at concentrations where any synergistic eects of the proteins could be detected. ceBNIP3 has low killing activity at this concentration and CED-3 induces around 20 ± 30% of cell death (Figure 9b ). When transfected together or in presence of CED-4, no increase other than a small additive eect was detected after 6, 9 and 12 h post-transfection. In contrast, CED-4 greatly enhanced CED-3 activity, which was eciently blocked by CED-9.
Discussion
In this report, we have studied the C. elegans ortholog of BNIP3 and showed that ceBNIP3 shares common features with mammalian BNIP3 and NIX in its Figure 7 Regulation of ceBNIP3 protein expression by the proteasome. TS20 (a) and H38 parental cells (b) were transfected with T7-ceBNIP3. After 12 h post transfection, cells were shifted to 398C, harvested at the indicated times and Western blots were developed with mouse monoclonal anti-T7 antibody. TS20 cell lysates (c) were also immunoblotted with a p53 antibody to show that ubiquitination was eciently blocked as it was only detectable at 398C primary amino acid sequence, localization, ability to induce apoptosis, homodimerization, heterodimerization and protein degradation. The amino acid identity between these proteins is only 21%, however the homology between other C. elegans and mammalian cell death proteins such as CED-9 and BCL-2, and CED-3 and caspase 1 is only 23 and 29% identity, respectively.
BNIP3, NIX and ceBNIP3 proteins contain PEST sequences and are rapidly degraded by the proteasome when overexpressed. In mammalian cells, two mechanisms target proteins to the proteasome, the ®rst is based on the PEST sequence that is characterized by a stretch of amino acids rich in proline, glutamic acid, serine and threonine¯anked between charged amino acids (Rogers et al., 1986) . The second is protein ubiquitination (Hochstrasser, 1996) . Ubiquitination and proteasome could be involved in the regulation of apoptosis by promoting the turn over of antiapoptotic proteins or by degradation of pro-apoptotic proteins. For example after induction of apoptosis in thymocyte, the IAP anti-apoptotic proteins are degraded by the proteasome (Yang et al., 2000) . The degradation is dependent on the RING domain, which catalyses an auto-ubiquitination event. In TS20 cells, defective ubiquitination has been shown to induce apoptosis through a caspase independent pathway and can be suppressed by BCL-2 (Monney et al., 1998) . Table 1 Interaction of ceBNIP3 with CED-9 and BCL-x L in the yeast two hybrid system
Yeast strain KGY37 was co-transformed with indicated GAL4 binding domain (BD) and activating domain (AD) constructs. The relative level of activation for the HIS3 reporter gene was determined by growth (+) or no growth (7) on selection medium lacking tryptophan, leucine and histidine in the presence of 1 mM 3-amino-1,2,4-triazole (3AT)
Oncogene BH3-and caspase-independent killing by CeBNIP3 J Cizeau et al
Another study showed that BAX could be degraded by a ubiquitin proteasome-dependent pathway that correlates with an increase in the survival human cancer cells (Li and Dou, 2000) . The data obtained in the present study using the TS20 cells and lactacystin show that ceBNIP3 is degraded through an ubiquitindependent step and requires an active proteasome. The signi®cance of this event in relation to apoptosis is unknown. It is possible that the direct ubiquitination of ceBNIP3, BNIP3 and NIX is responsible for its activation by allowing the protein to be cleaved by the proteasome, or ubiquitination modi®es the conformation of the protein. The ubiquitination of an unknown ceBNIP3 binding protein could also be regulatory, possibly by permitting the displacement of ceBNIP3 from an inactive complex. ceBNIP3, BNIP3 and NIX share a highly conserved domain of 19 amino acids, however deletion of this region has no eect on ceBNIP3-inducing cell death. Because of its evolutionary conservation, we suspect that the domain must contribute to ceBNIP3 regulation. It is possible that ceBNIP3, BNIP3 and NIX may interact with other proteins or can be post-translationally modi®ed through the conserved domain. However, this region is not important for interaction with CED-9 or BCL-X L . Deletion of the conserved domain also creates a partial deletion of the putative BH3 domain. The BH3 domain of pro-apoptotic proteins forms an amphipathic a-helix that binds in the hydrophobic pocket created by the BH1, BH2 and BH3 domains of BCL-X L (Kelekar and Thompson, 1998) . The deletion of the BH3 domain of BNIP3 has no eect (Ray et al., 2000) or only partially blocks apoptosis (Yasuda et al., 1998a) suggesting that another portion of the protein may also be involved. The data presented in this study demonstrated that deletion of the ceBNIP3 BH3 domain had no eect on the apoptotic activity of the protein, indicating that it is not a classical proapoptotic BH3-only protein. Alignment of the BH3 domains of dierent pro-apoptotic BCL-2 family members shows that the core has a leucine at position 1 and an aspartic acid at position 6 (Kelekar and Thompson, 1998) . However, the putative BH3 domain of ceBNIP3 contains the conserved leucine but the conserved aspartic acid is at position 8 (Figure 1b) due to the insertion of two proline residues at positions 2 and 3, therefore making it unlikely that this region could form an a-helix.
Sequence analysis of ceBNIP3 revealed a a-helical hydrophobic domain in the C-terminus of the protein that could be a TM domain. Like BNIP3 and NIX, the TM domain is required for homodimerization in yeast two hybrid system (Chen et al., 1997; Ray et al., 2000) . Interestingly, ceBNIP3 and BNIP3 also heterodimerize through the TM domain despite only a few conserved amino acids suggesting that the functional speci®city of the region has been conserved. Transiently transfected ceBNIP3 localized to the mitochondria and the cells underwent apoptosis, but not ceBNIP3DTM indicating that its activity depends on its mitochondrial localization, similar to BNIP3 and NIX (Chen et al., 1997 . The b-galactosidase assay showed that overexpression of ceBNIP3 in mammalian cells induced cell death almost as eciently as BNIP3 with 40% at 12 h and reaching 60% by 48 h. In contrast, chromatin condensation detected by Hoechst staining was under 10% after 12 h for ceBNIP3 and BNIP3. These data show that chromatin condensation is a late event compared to the global morphological changes induced by ceBNIP3 overexpression.
EGL-1 has been shown to interact with CED-9 through its BH3 domain and allows the release of CED-4 and CED-3 from the complex with CED-9. In this report, we found that ceBNIP3 interacts with CED-9 and BCL-X L . Deletion mapping showed that the putative BH3 and conserved domains did not suppress this binding. In contrast, the deletion of the TM domain signi®cantly reduced the interaction with CED-9 and BCL-X L . The presence of a faint band after over exposure suggests that ceBNIP3 may also weakly bind CED-9 and BCL-X L through another domain. The same type of interaction has been described between BCL-2 or BCL-X L and Bap31. Bap31 is a pro-apoptotic protein associated with the endoplasmic reticulum that interacts with BCL-2 or BCL-X L , a CED-4 like protein and pro-caspase 8 (Ng et al., 1997) . In vitro and in vivo studies have shown that BCL-2 or BCL-X L bind directly Bap31 to the N- terminal domain that contains three TM domains (Ng et al., 1997; Ng and Shore, 1998) . The binding domain of ceBNIP3 with CED-9 is therefore distinct from EGL-1. ceBNIP3 is the ®rst C. elegans pro-apoptotic protein that has been shown to localize to the mitochondria in mammalian cells. In response to an apoptotic signal, the role of the mitochondria in C. elegans is still obscure but in mammalian cells, it plays an important role by releasing cytochrome c and Dcm disruption (Green and Reed, 1998) , subsequently activating the caspase cascade. We have shown that overexpression of BNIP3 induces opening of the PT pore, which leads to a loss of Dcm and ROS production . Therefore, ceBNIP3 may also disrupt the function of the mitochondria in a similar manner. In contrast to other inducers of cell death, BNIP3 does not induce the release of cytochrome c and cell death is not blocked by the broad spectrum of caspase inhibitor AczVAD.fmk . Ac-zVAD.fmk also has no eect on ceBNIP3, implying that it uses a caspase-independent cell death pathway. This lack of participation of caspases in cell death is also seen in ceBNIP3 and CED-3 co-transfection. Despite evidence of interaction between ceBNIP3 and CED-3 by coimmunoprecipitation, expression of both proteins does not signi®cantly increase cell death compared to cotransfection of CED-3 and CED-4. So ceBNIP3 may act as a docking protein allowing the proper positioning of CED-3 in vivo, but it does not act as a CED-4-like protein to promote CED-3 activation.
In conclusion, we have characterized the orthologue of BNIP3 in C. elegans, ceBNIP3. ceBNIP3 is capable of rapidly activating cell death and interacting with CED-9 and CED-3. However, it kills through a BH3-and caspase-independent mechanism.
Materials and methods
Cell cultures and reagents
MCF-7 breast carcinoma cells, 10T1/2 ®broblast cells, and the BALB/c 3T3 TS20 and H38 cell lines were cultured in aminimal essential medium (a-MEM) (GIBCO, BRL) supplemented with 10% fetal bovine serum (GIBCO, BRL), 1% glutamine (GIBCO, BRL), 1% HEPES (GIBCO, BRL) and 1% MEM sodium pyruvate (GIBCO, BRL). 293T human embryonic kidney cells were cultured in Dulbecco's Modi®ed Eagle Medium (D-MEM) (GIBCO, BRL) supplemented with 10% fetal bovine serum. Anti-rabbit HSP60 antibody was kindly provided by Dr Radhey Gupta (McMaster University, Hamilton, ON, Canada).
Cloning and construction of expression plasmids
The ceBNIP3 cDNA was obtained by polymerase chain reaction (PCR) from a C. elegans cDNA library generously donated by Dr Pete Okkema (University of Illinois, Chicago, IL, USA) using the primer pair: 5'-ACAATGTCCT-CATTTCTTGAG-3' and 5'-TCATTGACGATGATGTTT-TAG-3'. To construct the T7 epitope-tagged ceBNIP3 in pcDNA3 (Invitrogen Corp.), a cDNA fragment encoding T7 was inserted into the HindIII and KpnI sites of the vector. Restriction sites KpnI and BamHI were introduced by PCR at the 5' and 3' ends of the insert respectively. The fragment was then cloned into KpnI and BamHI sites of pcDNA3-T7.
Deletion mutants of the TM (amino acids 189 ± 210), ceBNIP3DTM, the putative BH3 domain (amino acids 124 ± 142) ceBNIP3DBH3, the double deletion mutant DTMBH3 and the conserved domain (amino acids 132 ± 151), ceB-NIP3DCD, ceBNIP3DN1 deletion of the ®rst 26 amino acids, ceBNIP3DN2 deletion of the ®rst 54 amino acids were introduced into ceBNIP3 by site directed mutagenesis using PCR. HA-CED-9 and FLAG-CED-3 expression plasmids were kindly provided by Dr Gabriel Nunez (University of Michigan, Ann Harbor, MI, USA) and Myc-BCL-X L by Dr Gordon Shore (McGill University, Montreal, PQ, Canada).
For yeast transformations, plasmids encoding ceBNIP3 and ceBNIP3DTM with suitable restriction sites were generated by PCR and then ligated in frame into the GAL4 binding domain of pGBT9 and the GAL4 transcription activating domain of pACTII . The pGBT9 or pACTII constructs containing BNIP3 have been described previously (Chen et al., 1997; Ray et al., 2000) . The nucleotide sequence of all constructs was con®rmed using an ABI 310 Genetic Analyser (Applied Biosystems, Foster City, CA, USA).
Yeast transformations
The pGBT9 and pACTII constructs were co-transformed into yeast strain KGY37 and plated on synthetic complete (SC) selection media lacking leucine and tryptophan. Protein ± protein interactions were determined by growth on SC selection medium lacking leucine, tryptophan and histidine in the presence of 1 mM 3-amino-1,2,4,triazole (3AT).
In vitro translation
35
S-labeled ceBNIP3, BNIP3 and deletion mutants of both proteins were prepared by in vitro transcription and translation of cDNAs cloned into pcDNA3-T7 vector using the TnT coupled Reticulocyte Lysate System (Promega Corp., Madison, WI, USA), according to the manufacturer's instructions.
Transient transfection and cell death assays
Aliquots of 1610 5 293T cells were seeded in 6-well plates and then transfected by the calcium phosphate precipitation method using 2 mg of expression plasmid. MCF-7 (1610 5 ), 10T1/2 (1610 5 ) cells stably transfected with Bcl-X L and 2.5610 4 10T1/2 cells were transfected with 1 mg of expression plasmid using 7 ml of LipofectAMINE Reagent (GIBCO, BRL). Cells were plated on coverslips in 6-well plates and were incubated with the DNA-LipofectAMINE mixture for 5 h and then ®xed with 4% formaldehyde in PBS at the indicated time. Cells were stained with mouse monoclonal anti-T7 antibody (Novagen, Madison, WI, USA) and visualized with FITC-conjugated goat anti-mouse IgG secondary antibody (Sigma Chemical Co, St. Louis, MO, USA). The nuclei were stained with Hoechst dye. Approximately 200 transfected cells were scored as apoptotic or nonapoptotic using a Zeiss axiophot microscope.
For the b-galactosidase assay, 293T cells were cotransfected with 0.05 mg of reporter plasmid, pcDNA3-bgalactosidase, plus 0.5 mg of the indicated plasmid for 4 h using LipofectAMINE reagent. Ac-zVAD.fmk or Ac-FA.fmk (Enzyme System Product, Dublin, CA, USA) was added to a ®nal concentration of 50 or 100 mM and the cells were stained at the indicated time as described previously (Miura et al., 1993) . Similar assay was repeated to measure the ceBNIP3, CED-3 and CED-4 killing activity. The reporter gene, pcDNA3-b-galactosidase, was used at 0.01 mg and the various plasmids at 0.025 mg. pcDNA3 was added to keep the concentration of DNA equal between dierent transfection experiments.
For subcellular localization, MCF-7 cells were transfected with expression plasmids using LipofectAMINE as described above. The cells were ®xed and double stained with mouse monoclonal anti-T7 (Novagen, Madison, WI, USA) and rabbit polyclonal anti-HSP60 antibody 24 h post-transfection, and visualized with goat anti-mouse Cy3-conjugated antibody (Chemicon, Temecula, CA, USA) and goat antirabbit FITC-conjugated antibody (Sigma Chemical Co, St. Louis, MO, USA) respectively. Samples were analysed using a confocal¯uorescence microscope equipped with an argon laser and dual detectors (Molecular Dynamics, Sunnyvale, CA, USA). The images were acquired with Image Space software using a 60 objective lens and then transferred into Adobe Photoshop for printing.
Co-immunoprecipitation
293T cells (2 ± 5610 6 ) were transfected with 4 mg of indicated plasmids by the calcium phosphate method. After 15 h post transfection, cells were collected and resuspended in lysis buer containing 100 mM Tris pH 8, 2 mM EDTA, 100 mM NaCl, 0.2% NP-40 and protease inhibitors. The lysates were sonicated for 10 s three times, centrifuged for 10 min and precleared with protein A-sepharose 4B (Zymed, Laboratories Inc.) for 30 min at 48C. Equal volumes of binding buer containing 200 mM NaCl, 20% glycerol and 0.2% NP-40 were added with 1 mg of antibody and then incubated for 2 h at 48C. Mouse monoclonal anti-T7 antibody was purchased from Novagen (Madison, WI, USA), rabbit anti-HA antibody from Santa Cruz (San Diego, CA, USA) and the mouse monoclonal anti-Myc antibody was a gift from Dr J Wright (Manitoba Institute of Cell Biology, Winnipeg, MB, Canada), the mouse monoclonal anti-FLAG antibody from Sigma Chemical Co. (St. Louis, MO, USA) and the polyclonal rabbit anti-FLAG antibody from Zymed (San Francisco, CA, USA). Immune complexes were captured with protein A-sepharose 4B. Immunoprecipitates were subjected to 10% SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) and immunoblotted with mouse monoclonal anti-T7, mouse monoclonal anti-HA (Boehringer Mannheim, Indianapolis, IN, USA) or rabbit anti-BCL-X L antibody (PharMingen, Mississauga, ON, Canada).
Western blotting
Aliquots of 5610 5 transfected cells were resuspended in SDS sample buer and electrophoresed by the Laemmli SDS ± PAGE method or SDS ± PAGE using Tris-Tricine buer and PVDF membrane (Horton et al., 1993) and were immunoblotted with anti-T7 antibody using an ECL detection kit according to the manufacturer's instructions (Amersham, Amersham, UK).
